Autem Therapeutics
PrivateLast Round
Series A
Extension
Jun 6, 2022
Total Funding Raised
$14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Autem Therapeutics is an oncology and bioelectric technology company developing a non-invasive, non-toxic treatment platform for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autem Therapeutics Comparables
Compare Autem Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraBionic | 86% | |
| EMulate Therapeutics | 85% | |
| QV Bioelectronics | 82% | |
Autem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 6, 2022 |
Key People
Founding team and executive leadership
Autem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Series A Extension |
| Spectra Investimentos | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 203% MoM.
- Nov 8, 2025
Monthly visitors increased 527% MoM to 2.1K.
Autem Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autem Therapeutics's valuation, stock price, and market status.